Intrinsic Value of S&P & Nasdaq Contact Us

RenaissanceRe Holdings Ltd. RNR NYSE

NYSE • Financial Services • Insurance - Reinsurance • BM • USD

SharesGrow Score
76/100
4/7 Pass
SharesGrow Intrinsic Value
$579.40
+88%
Analyst Price Target
$295.00
-4.3%

RenaissanceRe Holdings Ltd. (RNR) is a Insurance - Reinsurance company in the Financial Services sector, currently trading at $308.20. It has a SharesGrow Score of 76/100, indicating a strong investment profile with 4 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of RNR = $579.40 (+88% from the current price, the stock appears undervalued). Analyst consensus target is RNR = $295 (-4.3% upside).

Valuation: RNR trades at a trailing Price-to-Earnings (P/E) of 5.2 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.54.

Financials: revenue is $12.7B, +39.2%/yr average growth. Net income is $2.7B, growing at +111.7%/yr. Net profit margin is 21% (strong). Gross margin is 40.7% (-59.3 pp trend).

Balance sheet: total debt is $2.3B against $11.6B equity (Debt-to-Equity (D/E) ratio 0.2, conservative). Current ratio is 5.03 (strong liquidity). Debt-to-assets is 4.3%. Total assets: $53.8B.

Analyst outlook: 7 / 28 analysts rate RNR as buy (25%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 84/100 (Pass), Growth 100/100 (Pass), Past 75/100 (Partial), Health 100/100 (Pass), Moat 62/100 (Partial), Future 26/100 (Fail), Income 85/100 (Pass).

$295.00
▼ 4.28% Downside
Average Price Target
Based on 28 Wall Street analysts offering 12-month price targets for RenaissanceRe Holdings Ltd., the average price target is $295.00, with a high forecast of $313.00, and a low forecast of $267.00.
Highest Price Target
$313.00
Average Price Target
$295.00
Lowest Price Target
$267.00

RNR SharesGrow Score Overview

76/100
SharesGrow Score
Strong investment profile
View full scorecard →
VALUE 84/100
Valuation — P/E, PEG, Forward PEG
GROWTH 100/100
Financials — average growth
PAST 75/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 62/100
Gross margin is + market cap
FUTURE 26/100
Analyst outlook — as buy
INCOME 85/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — RNR

VALUE Pass
84/100
RNR trades at a trailing Price-to-Earnings (P/E) of 5.2 (S&P 500 average ~25). Forward PEG 0.54 — Peter Lynch undervalued (≤1.0). Trailing PEG 0.09. Analyst consensus target is $295, implying -4.3% from the current price $308. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
GROWTH Pass
100/100
RNR: +39.2%/yr revenue is, +111.7%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
~
PAST Partial
75/100
RNR: 3 / 4 years profitable. mixed. Score = 3 / 4 × 100. ≥ 80 = Pass.
View details →
HEALTH Pass
100/100
Balance sheet RNR: Debt-to-Equity (D/E) ratio 0.2 (conservative), Current ratio is 5.03 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
62/100
RNR: Gross margin is 40.7% (-59.3 pp trend), $13B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 62/100. ≥ 70 = Pass.
View details →
FUTURE Fail
26/100
Analyst outlook: 7 / 28 analysts rate RNR as buy (25%). Analyst consensus target is $295 (-4.3% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
INCOME Pass
85/100
RNR: Net profit margin is 21%. healthy (≥15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range219-315.88
Volume233.4K
Avg Volume (30D)363.24K
Market Cap$13.4B
Beta (1Y)0.24
Dividend Yield$1.6100
Share Statistics
EPS (TTM)56.76
Shares Outstanding$44.87M
IPO Date1995-07-27
Employees945
CEOKevin Joseph O'Donnell
Financial Highlights & Ratios
Revenue (TTM)$12.75B
Gross Profit$5.18B
EBITDA$4.14B
Net Income$2.68B
Operating Income$4.01B
Total Cash$32.96B
Total Debt$2.33B
Net Debt$598.02M
Total Assets$53.8B
Price / Earnings (P/E)5.4
Price / Sales (P/S)1.05
Analyst Forecast
1Y Price Target$303.00
Target High$313.00
Target Low$267.00
Upside-1.7%
Rating ConsensusHold
Analysts Covering28
Buy 25% Hold 68% Sell 7%
Price Target Summary
Company Info
CountryBM
ExchangeNYSE
CurrencyUSD
ISINBMG7496G1033

Price Chart

RNR
RenaissanceRe Holdings Ltd.  ·  NYSE
Financial Services • Insurance - Reinsurance
219.00 52WK RANGE 315.88
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message